MAML1 and cancer: This study also demonstrated that CD44 is a direct NOTCH1 target, whose transcription is regulated by MAML1/CSL-binding to its proximal promoter, but also through dynamic interactions with a superenhancer, which is a mechanism shared with other NOTCH1 targets involved in development and cancer, such as IL7R [30,31].